Quantcast

Latest research Stories

2014-06-16 04:21:36

LUGANO, Switzerland, June 16, 2014 /PRNewswire/ -- ESMO welcomes the adoption of the Clinical Trials Regulation by the EU The European Society for Medical Oncology (ESMO) has welcomed the adoption of the Clinical Trials Regulation [http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=uriserv:OJ.L_.2014.158.01.0001.01.ENG ] by the EU, entering into force today. The new framework acknowledges the importance of using data stored for a clinical trial beyond the end of...

2014-06-15 08:20:51

LONDON, June 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/drug_discovery/hormone_refractory_breast_cancer_global_clinical_trials_review_h1_2014.htmlHormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014 SummaryGlobalData's clinical trial report, "Hormone Refractory Breast Cancer Global Clinical Trials...

2014-06-13 08:24:31

SCRS Welcomes INC Research, inVentiv Health, Novartis and Sanofi ELLICOTT CITY, Md., June 13, 2014 /PRNewswire/ -- Leading sponsor and CRO organizations continue to join the Society for Clinical Research Sites' (SCRS) Global Impact Partner (GIP) program at a rapid pace. Since April 1, INC Research, inVentiv Health, Novartis and Sanofi have joined the SCRS GIP program. From its inception only one year ago, the initiative has quickly grown to 25 leading organizations. Global Impact...

2014-06-13 08:24:05

SOUTH PLAINFIELD, N.J., June 13, 2014 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that Shane Kovacs, Chief Financial Officer, has received the 2014 Deal of the Year Award from the New Jersey Technology Council (NJTC). The Deal of the Year Award is part of the annual NJTC CFO Awards Breakfast, which recognizes the accomplishments of financial executives from the region's diverse technology community. http://photos.prnewswire.com/prnvar/20010919/PTCLOGO "I am...

2014-06-12 08:35:19

Research Accepted as Podium Presentation at the American Diabetes Association 74th Scientific Sessions BOWIE, Md., June 12, 2014 /PRNewswire/ -- Inovalon, Inc., a leading technology company providing advanced cloud-based analytics and data-driven solutions to the healthcare industry, today announced a comparative safety research study to be presented at the American Diabetes Association 74(th) Scientific Sessions June 13-17 in San Francisco, California. The study was supported by...

2014-06-12 08:28:44

WCCT Global to Attend the 2014 DIA Meeting in San Diego COSTA MESA, Calif., June 12, 2014 /PRNewswire-iReach/ -- WCCT Global (WCCTG), a Southern California headquartered Full Service Contract Research Organization announced today that the organization will be attending the 2014 DIA meeting in San Diego, California. WCCT Global will be an exhibitor at booth #821. WCCTG will be sharing information about many of the exciting clinical research services the company has both added and...

2014-06-12 08:28:37

SANTA ROSA, Calif., June 12, 2014 /PRNewswire/ -- Ruthigen, Inc., (NASDAQ: RTGN), a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics designed to prevent and treat infection in invasive applications, is pleased to announce today that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application without a clinical hold to begin human clinical testing of RUT58-60. Ruthigen...

2014-06-11 23:08:39

Premier Research presents an exciting live webinar on Thursday, June 26, 2014 at 11:00am EDT (16:00 UK BST/ GMT +1) exploring how the TPP process can provide companies with a clear advantage in early clinical development, leading to the greatest possibility of approval and successful product launch. Toronto, Canada (PRWEB) June 11, 2014 What if a product has the ability to achieve multiple indications in multiple therapeutic areas? How would one decide the best way to proceed in order to...

2014-06-11 23:07:15

Letter Cited Several Issues Found After Inspection of Company’s Minnesota Plant Dallas, TX (PRWEB) June 11, 2014 The national law firm of Baron and Budd reports that the Food and Drug Administration (FDA) issued a warning letter to American Medical Systems, a manufacturer of transvaginal mesh devices. The letter was in regard to issues the FDA found at a facility run by the company, including procedures involving risk analysis and process validation procedures. The parent company of...

2014-06-11 23:03:30

Panelists will offer insights into their story selection process and areas of interest. Washington (PRWEB) June 11, 2014 Reporters covering various aspects of the drug and medical device development industry will share their experiences during a Reporters Round Table on June 17 at 8 a.m. at the DIA 2014 50th Annual Meeting, in Room 16B at the San Diego Convention Center. Panelists will offer insights into their story selection process and areas of interest. This is a unique opportunity...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related